Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the safety and tolerability of JZP-110 administered once daily for up to 52 weeks in doses of 75, 150, and 300 mg.
Critère d'inclusion
- Treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea; to increase the ability to stay awake throughout the day